GR3006948T3 - - Google Patents

Info

Publication number
GR3006948T3
GR3006948T3 GR920402866T GR920402866T GR3006948T3 GR 3006948 T3 GR3006948 T3 GR 3006948T3 GR 920402866 T GR920402866 T GR 920402866T GR 920402866 T GR920402866 T GR 920402866T GR 3006948 T3 GR3006948 T3 GR 3006948T3
Authority
GR
Greece
Prior art keywords
optionally substituted
means hydrogen
residue
branched
halogen
Prior art date
Application number
GR920402866T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006948T3 publication Critical patent/GR3006948T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR920402866T 1987-12-14 1993-01-29 GR3006948T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873742716 DE3742716A1 (de) 1987-12-14 1987-12-14 Imidazolderivate ii

Publications (1)

Publication Number Publication Date
GR3006948T3 true GR3006948T3 (el) 1993-06-30

Family

ID=6342780

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402866T GR3006948T3 (el) 1987-12-14 1993-01-29

Country Status (8)

Country Link
US (1) US5179111A (el)
EP (1) EP0323799B1 (el)
JP (1) JPH01279872A (el)
AT (1) ATE82285T1 (el)
CA (1) CA1330341C (el)
DE (2) DE3742716A1 (el)
ES (1) ES2052768T3 (el)
GR (1) GR3006948T3 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3824658A1 (de) * 1988-07-15 1990-01-18 Schering Ag N-hetaryl-imidazolderivate
WO1991002731A1 (de) * 1989-08-19 1991-03-07 Boehringer Ingelheim Kg Substituierte n-heterocyclen, ihre herstellung und verwendung
DE4112451A1 (de) * 1991-04-12 1992-10-15 Schering Ag Isoxazolylimidazolderivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
DE4432391A1 (de) * 1994-09-02 1996-03-07 Schering Ag Neues Verfahren zur Herstellung von I-Phenyl-imidazolderivaten
WO1999038829A1 (fr) * 1998-01-28 1999-08-05 Shionogi & Co., Ltd. Nouveau compose tricyclique
WO2007042544A2 (en) * 2005-10-14 2007-04-19 Neurosearch A/S Imidazole derivatives and their use for modulating the gabaa receptor complex
US7939556B2 (en) 2005-10-14 2011-05-10 Neurosearch A/S Imidazole derivatives and their use for modulating the GABAA receptor complex
US20080312303A1 (en) * 2005-10-14 2008-12-18 Neurosearch A/S Imidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
CA2962431A1 (en) 2014-09-25 2016-03-31 University Of Notre Dame Du Lac Non-beta lactam antibiotics
WO2018049404A1 (en) 2016-09-12 2018-03-15 University Of Notre Dame Du Lac Compounds for the treatment of clostridium difficile infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3444918A1 (de) * 1984-12-08 1986-06-12 Hoechst Ag, 6230 Frankfurt 1-phenyl-imidazol-5-carbonsaeure-derivate, ein verfahren zu ihrer herstellung und ihre verwendung als wachstumsregulatoren
US4771051A (en) * 1985-05-17 1988-09-13 A/S Ferrosan 3-substituted-4,5-dihydro-5-oxo imidazoquinazolines, their preparation, and their use in treating benzodiazepin receptor-related ailments
US4852132A (en) * 1985-08-30 1989-07-25 Yokogawa Medical Systems Method of collecting data for x-ray tomograph
DE3627155A1 (de) * 1986-08-11 1988-02-18 Schering Ag Imidazol-derivate
EP0284277A1 (en) * 1987-03-21 1988-09-28 AgrEvo UK Limited Cyanoimidazole fungicides

Also Published As

Publication number Publication date
DE3875945D1 (de) 1992-12-17
EP0323799B1 (de) 1992-11-11
ES2052768T3 (es) 1994-07-16
CA1330341C (en) 1994-06-21
US5179111A (en) 1993-01-12
JPH01279872A (ja) 1989-11-10
EP0323799A1 (de) 1989-07-12
ATE82285T1 (de) 1992-11-15
DE3742716A1 (de) 1989-06-22

Similar Documents

Publication Publication Date Title
DE3560531D1 (en) Redox indicators
US4476308B1 (el)
GR3006948T3 (el)
NO165108C (no) Analogifremgangsmaate for fremstilling av teraputisk aktive beta-laktamantibiotika.
TW263513B (el)
ES8301221A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
DK19182A (da) Fremgangsmaade til fremstilling af phenylpiperazinyl-propaner af heterylphenoler
AU7446287A (en) Hydroxypyrazole derivatives, their preparation and their use against microorganisms
SE7503868L (sv) Forfarande for framstellning av bensobicyklonenderivat.
ES471354A1 (es) Procedimiento para la obtencion de derivados de r,s-2-(2 hi-droxietilamina)-1-fenil-etilamina
AU5455780A (en) Hexahydro-1,4-oxazepines
ATE5318T1 (de) 4-niedrig-hydrocarbyl-3-phenoxypyridin-1-oxide, verfahren zu ihrer herstellung, diese verbindungen enthaltende zusammensetzungen und ihre verwendung.
DE59106137D1 (de) Oasomycine, Verfahren zu ihrer Herstellung und ihre Verwendung.
CA1251790A (en) PYRROLE[1,2-B][1,2,5] TRIAZEPINES, METHOD AND INTERMEDIATES FOR THEIR PREPARATION AND USE AS MEDICINES
ES8100285A1 (es) Procedimiento para fabricar derivados de dimeros del isoeugenol
DE3265847D1 (en) Diglycidyl pteridine compounds, method for their preparation and their use in drugs with a cytostatic activity
GR3000725T3 (en) 3-amino-dihydropyridines, process for their preparation and their use as medicaments
IT1290403B1 (it) Analoghi del metabolita attivo della leflunomide